
Beneficient (NASDAQ:BENF – Free Report) – Sidoti Csr dropped their Q2 2026 earnings estimates for shares of Beneficient in a report released on Tuesday, November 4th. Sidoti Csr analyst B. Mccarthy now expects that the company will post earnings of ($0.32) per share for the quarter, down from their previous estimate of ($0.29). The consensus estimate for Beneficient’s current full-year earnings is ($2.29) per share. Sidoti Csr also issued estimates for Beneficient’s Q3 2026 earnings at ($0.23) EPS, FY2026 earnings at ($1.53) EPS, Q1 2027 earnings at ($0.26) EPS and FY2027 earnings at ($0.31) EPS.
Other analysts also recently issued reports about the company. Wall Street Zen upgraded Beneficient to a “sell” rating in a research note on Saturday, November 1st. Weiss Ratings reiterated a “sell (e+)” rating on shares of Beneficient in a research report on Wednesday. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.
Beneficient Stock Down 3.6%
Beneficient stock opened at $0.51 on Thursday. Beneficient has a 12 month low of $0.22 and a 12 month high of $2.36. The stock’s 50 day moving average is $0.58 and its 200-day moving average is $0.41.
Beneficient (NASDAQ:BENF – Get Free Report) last released its quarterly earnings results on Tuesday, October 21st. The company reported ($0.85) earnings per share for the quarter. The business had revenue of ($12.62) million for the quarter.
About Beneficient
Beneficient, a technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States. It operates through Ben Liquidity, Ben Custody, and Customer ExAlt Trusts segments.
Read More
- Five stocks we like better than Beneficient
- Business Services Stocks Investing
- OpenAI’s Restructuring Sets up What Could Be the Biggest IPO Ever
- What Are Some of the Best Large-Cap Stocks to Buy?
- 2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- CrowdStrike Partners With CoreWeave But Investors Sell the News
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.
